Cargando…
Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients
The aim was to evaluate the effects of traditional Chinese medicine (TCM) as a combination medication with adjuvant chemotherapy on postoperative early stage non-small cell lung cancer (NSCLC) patients. The 314 patients with completely resected stage IB, II or IIIA cancers were assigned into vinorel...
Autores principales: | Jiao, Lijing, Dong, Changsheng, Liu, Jiaxiang, Chen, Zhiwei, Zhang, Lei, Xu, Jianfang, Shen, Xiaoyong, Che, Jiaming, Yang, Yi, Huang, Hai, Li, Hegen, Sun, Jianli, Jiang, Yi, Mao, Zhujun, Chen, Peiqi, Gong, Yabin, Jin, Xiaolin, Xu, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402288/ https://www.ncbi.nlm.nih.gov/pubmed/28436479 http://dx.doi.org/10.1038/srep46524 |
Ejemplares similares
-
Adjuvant Chemotherapy with Chinese Herbal Medicine Formulas Versus Placebo in Patients with Lung Adenocarcinoma after Radical Surgery: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Wang, Qin, et al.
Publicado: (2020) -
Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients
por: Xu, Ling, et al.
Publicado: (2012) -
Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial
por: Wang, Qin, et al.
Publicado: (2018) -
Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Jiao, Lijing, et al.
Publicado: (2019) -
The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial
por: Yao, Jialin, et al.
Publicado: (2020)